Medican Enterprises Inc. (MDCN) 0.0080 $MDCN Medican

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medican Enterprises Inc. (MDCN) 0.0080 $MDCN

Medican Enterprises close USD1.0m stock acquisition of TWYNS
M2 - Tue May 12, 6:10AM CDT
Medican Enterprises Inc (OTCBB:MDCN) announced on Tuesday that it has closed its acquisition of TWYNS, a company providing branding services for enterprises in the Cannabidiol (CBD) business.

Medican Enterprises Files 8K Announcing Closing of Acquisition of CBD Branding Company TWYNS
Business Wire - Mon May 11, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company", a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, announces that further to its press release of April 28, 2014 the Company has closed on its acquisition of TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock and is expected to add approximately $400,000 to Medican's annual revenues.

Medican Enterprises Closes Acquisition of CBD Branding Company TWYNS in All Stock Deal
Business Wire - Wed May 06, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company", a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, announces that further to its press release of April 28, 2014 the Company has closed on its acquisition of TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock and is expected to add approximately $400,000 to Medican's annual revenues.

Medican Enterprises Signs Definitive Purchase Agreement to Acquire CBD Branding Company TWYNS for All Stock Transaction
Business Wire - Tue Apr 28, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company", a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, has signed a letter of intent to acquire TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock. TWYNS should add approximately $400,000 to Medican's revenue annually, and Medican is obligated to fund the operations of TWYNS at $12,000 per month.

Medican Enterprises announces extension of option for purchase of two Phoenix area properties
M2 - Mon Apr 20, 3:15AM CDT
Medican Enterprises Inc (OTCBB:MDCN.OB), a merchant bank and bio-pharmaceutical company in the marijuana industry, announced on Friday that it has extended the option to purchase two facilities in the Phoenix, Arizona, area.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VI
Anthony Cataldo - at Seeking Alpha - Sun Apr 19, 4:00AM CDT


Medican Enterprises Extends Closing on Two Phoenix Area Properties
Business Wire - Fri Apr 17, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican" or "the Company", a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, is pleased to announce that it continues to raise capital in the market place and has extended the option to purchase two facilities in the Phoenix, AZ, area.

Penny Stocks Movers for Medican Enterprises, Advanced Medical Isotope, Radiant Creations Group, CIG Wireless, MRI Interventions, and NuGene
PR Newswire - Wed Mar 25, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Medican Enterprises (OTCMKTS:MDCN), Advanced Medical Isotope (OTCMKTS:ADMD), Radiant Creations Group (OTCBB:RCGP), CIG Wireless (OTCBB:CIGW), MRI Interventions (OTCBB:MRIC), and NuGene (OTCBB:NUGN).

Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST


48 Marijuana Stocks - A Post-Mortem: Part I
Anthony Cataldo - at Seeking Alpha - Tue Mar 03, 1:27AM CST

GWPH: 112.25 (-0.07)

Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST


Medican Enterprises and JTB Real Estate extend closing date of Arizona property acquisition deal
M2 - Thu Feb 19, 6:31AM CST
Medican Enterprises Inc (OTCBB:MDCN.OB), a company seeking opportunities in the medical and recreational marijuana sector, announced on Wednesday that with JTB Real Estate LLLP (JTB), the companies have agreed to extend the closing date of the acquisition of 7,200 square foot retail and commercial property in Phoenix, Arizona.

Medican Enterprises and JTB Real Estate LLLP Agree to Extension of the Closing Date for the of Arizona Property Acquisition
Business Wire - Wed Feb 18, 11:58AM CST
Medican Enterprises Inc. (OTCBB:MDCN) (the "Company" or "Medican Enterprises", a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced today that the Company and JTB Real Estate LLLP ("JTB" have agreed to extend the closing date of the previously announced acquisition. The acquisition of the 7,200 square foot retail and commercial property in Phoenix, Arizona was detailed in the press release dated January 20, 2015. The building acquisition brings near-term revenue and cash flow potential. Both parties are aggressively working together to close on or before March 31, 2015.

Medican Forms Medican Nations to Partner with Indian Communities on Agriculture and Marijuana Businesses
Business Wire - Wed Feb 04, 7:00AM CST
Medican Enterprises Inc. (OTCBB:MDCN) today announced the formation of a new wholly owned subsidiary called Medican Nations, LLC (Medican Nations) and the appointment of Demitri Downing as Chief Executive Officer of Medican Nations.

Medican Enterprises Announces Extension to Closing of Acquisition Arizona Property
Business Wire - Fri Jan 30, 7:00AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announces that further to its press release of January 20, 2015 Medican has entered into a purchase agreement to acquire a retail and commercial property leased to a State Licensed Dispensary in Phoenix, Arizona.

Medican Enterprises Provides Shareholder Update
Business Wire - Wed Jan 28, 7:01AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, today has provided shareholders with an update on its corporate accomplishments and business development plans in a shareholder letter from Chief Executive Officer Kenneth Williams. It reads:

Medican Enterprises executes purchase agreement for 7200 square feet retail and commercial property in Phoenix, Arizona
M2 - Wed Jan 21, 4:44AM CST
Medican Enterprises Inc (OTC:MDCN), a company seeking business opportunities in the medical and recreational marijuana sector, announced on Tuesday that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

Medican Enterprises to Purchase 7200 sq ft Retail and Commercial Property in Phoenix
Business Wire - Tue Jan 20, 7:01AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VI
Anthony Cataldo - at Seeking Alpha - Fri Jan 16, 1:21PM CST

INSY: 59.00 (+0.17), GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Canada Navigates Operational Challenges Amid Storms

Updated Category News Views 205

Air Canada's Operational Challenges and Responses Air Canada has recently faced significant operational hurdles due to severe winter weather and an aircraft incident impacting its Toronto Pearson international hub. These challenges have necessitated a comprehensive update from the airline about its current status and ongoing recovery efforts. Recent Weather Impact on...

Continue Reading
Insight into Melexis' Ongoing Share Buy-Back Strategy

Updated Category News Views 128

Melexis Enhances Shareholder Value Through a Strategic Buyback Melexis, a leader in the semiconductor industry, has been actively engaging in a strategic share buy-back program aimed at bolstering shareholder value. This initiative, first announced on December 10, 2024, reflects the company's commitment to enhancing its stock's performance while also optimizing its...

Continue Reading
Value Line, Inc. Launches New Share Repurchase Initiative

Updated Category News Views 220

Value Line, Inc. Announces Stock Repurchase Program Value Line, Inc. (NASDAQ: VALU) recently revealed an exciting development for its shareholders: the Board of Directors has approved a share repurchase program that allows for the buyback of up to $2,000,000 worth of shares. This program comes into effect immediately and marks a significant move that replaces the previous...

Continue Reading
IsoEnergy Expands Stake in Premier American Uranium Inc. Assets

Updated Category News Views 154

IsoEnergy Enhances Investment in Premier American Uranium Inc. IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) has recently expanded its investment in Premier American Uranium Inc. by acquiring a significant number of common shares and warrants. This strategic move further establishes IsoEnergy’s commitment to capitalizing on the promising uranium market amid increasing...

Continue Reading
Texas Attorney General Takes Action Against Insulin Price Fixing

Updated Category News Views 70

Texas Attorney General's Lawsuit Against Insulin Price Fixing Texas Attorney General Ken Paxton has taken significant action by filing a lawsuit against several prominent insulin manufacturers and pharmacy benefit managers (PBMs). The lawsuit highlights allegations of a conspiracy to inflate insulin prices, affecting countless patients who rely on this vital medication....

Continue Reading